» Articles » PMID: 26398829

A Case of Atypical Carcinoid: Harboring Variant 3a/b EML4-ALK Rearrangement

Overview
Journal J Thorac Oncol
Publisher Elsevier
Date 2015 Sep 24
PMID 26398829
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Pulmonary carcinoid tumour with remarkably high levels of pro-gastrin-releasing peptide: A case report.

Nakagawa N, Kawakami M, Suzuki M, Noguchi S, Mitani A, Tanaka G Respir Med Case Rep. 2023; 43:101836.

PMID: 36950025 PMC: 10026027. DOI: 10.1016/j.rmcr.2023.101836.


Metastatic pulmonary carcinoids with fusion response to ALK inhibitors: two case reports and review of literature.

Lei X, Zhu S, Ren D, Ren F, Li T, Zhou N Transl Lung Cancer Res. 2022; 11(6):1176-1184.

PMID: 35832448 PMC: 9271430. DOI: 10.21037/tlcr-22-394.


Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)?.

Hiddinga B, Zwaenepoel K, Janssens A, Meerbeeck J, Pauwels P Oncotarget. 2022; 13:800-809.

PMID: 35677534 PMC: 9159705. DOI: 10.18632/oncotarget.28240.


Atypical Lung Carcinoid With EML4/ALK Fusion Detected With Circulating Tumor DNA.

Gococo-Benore D, Boyle A, Wylie N, Drusbosky L, Khoor A, Starr J Cureus. 2022; 14(2):e22276.

PMID: 35350512 PMC: 8933274. DOI: 10.7759/cureus.22276.


Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective.

Prisciandaro M, Antista M, Raimondi A, Corti F, Morano F, Centonze G Front Oncol. 2022; 12:780716.

PMID: 35186729 PMC: 8856722. DOI: 10.3389/fonc.2022.780716.